Last Updated on October 15, 2024 by The Health Master
FOR IMMEDIATE RELEASE – Exela Pharma Sciences, LLC, (Exela) is expanding its recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton.
Risk Statement: The product poses a potential safety concern with vial breakage and flying glass when pressurized while preparing the product for administration.
There is a potential of flying glass injuring the skin, eyes, and/or other parts which could result in either temporary or permanent injury.
Within the sixty-three (63) total recalled lots (which include more than 2.7 million vials), Exela has received five (5) reports of flying glass injuring the skin, eyes, and/or other parts.
There have been no complaints of vial breakage or injuries related to the additional fourteen (14) lots. There have been no reports of sterility failures to date with any of the sixty-three (63) lots.
The product is used for the treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.
The vials are labeled with Exela brand (Carton NDC: 51754-5001-5; Vial NDC: 51754-5001-1) and Civica brand (Carton NDC: 72572-740-20; Vial NDC: 72572-740-1).
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (USFDA).
Drug recall: Dr Reddy’s, Sun Pharma recall these drugs due to this reason
Drug recall: FDA issues nationwide recall for Ferric Carboxymaltose
Drug recall: These drugs recalled by Aurobindo for this reason
Drug recall: These products recalled by Dr Reddy’s, Cipla, and Aurobindo
Drug recall: Sodium Bicarbonate Injection recalled due to this reason
Drug recall: Acyclovir Sodium Injection recalled due to this reason
USFDA-Gujarat FDCA to meet to discuss GMP compliance, capacity building
CDSCO panel gives nod for Esomeprazole Dual Release Gastro resistant tablets
Drug recall: Dr. Reddy’s, Sun Pharma recall these drugs due to this reason
USFDA gives nod for Diclofenac Sodium topical solution
IPC releases amendment list for IP 2022, details here
NPPA releases 2nd list with draft ceiling prices for 43 formulations
USFDA gives approval for Venlafaxine ER tablets
Gujarat FDCA launches online licensing system for cosmetics
IPC to digitize Indian Pharmacopoeia (IP) soon
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
